CD4 and hepatocellular carcinoma: In contrast, similar to the notion that the tumor-targeting helper CD4 T cell is usually beneficial in the HCC stage, loss of specific subtypes of CD4 T cells that presumably recognize a neoantigen is important in the progression from NASH to HCC.